1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Hormone Replacement Therapy (HRT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017


DelveInsight’s Report, “Hormone Replacement Therapy (HRT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hormone Replacement Therapy (HRT) Report is to understand the market and pipeline status of the drugs around the Hormone Replacement Therapy (HRT) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hormone Replacement Therapy (HRT). While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 48-72 Hours to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:
- A snapshot of the global Market and Phase III therapeutics scenario for Hormone Replacement Therapy (HRT).
- A review of the marketed products under prescription for Hormone Replacement Therapy (HRT), regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Hormone Replacement Therapy (HRT) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Hormone Replacement Therapy (HRT) drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Hormone Replacement Therapy (HRT) drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Hormone Replacement Therapy (HRT) drugs.
- Coverage of Hormone Replacement Therapy (HRT) Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure to 2018.

Reasons to buy:
- Evaluate the marketing status and exclusivity details of Hormone Replacement Therapy (HRT) key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Hormone Replacement Therapy (HRT).
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Hormone Replacement Therapy (HRT).
- API intelligence over marketed drugs forHormone Replacement Therapy (HRT)and gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III Pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Hormone Replacement Therapy (HRT).
- Uncovering opportunities in the rapidly growing US market.

Table Of Contents

Hormone Replacement Therapy (HRT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
Illustrative
1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Hormone Replacement Therapy (HRT)
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Hormone Replacement Therapy (HRT)
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Hormone Replacement Therapy (HRT)
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer


List of Tables

- Hormone Replacement Therapy (HRT) Therapeutic Market, US, Marketed Drugs by Application Type, 2017
- Hormone Replacement Therapy (HRT) Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017
- Hormone Replacement Therapy (HRT) Therapeutic Market, US, (Year), 2017
- Hormone Replacement Therapy (HRT) Marketed Drugs, API Manufacturers by US DMF Status, 2017
- Hormone Replacement Therapy (HRT) Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Hormone Replacement Therapy (HRT) Drugs, API Manufacturers, Europe by Country, 2017
- Hormone Replacement Therapy (HRT) Drugs, API Manufacturers, India by State, 2017
- Hormone Replacement Therapy (HRT) Drugs, API Manufacturers, China by Province, 2017
- Hormone Replacement Therapy (HRT) Drugs, API Manufacturers by Geography 2017
- Hormone Replacement Therapy (HRT) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Hormone Replacement Therapy (HRT) Therapeutic Market, Global Sales-2018 (in million USD)
- API Manufacturers for Drug, 2017
- Phase III Drugs for Hormone Replacement Therapy (HRT), 2017
- Discontinued Drugs for Hormone Replacement Therapy (HRT), 2017


List of Figures

- Hormone Replacement Therapy (HRT) Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017
- Hormone Replacement Therapy (HRT) Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017
- Hormone Replacement Therapy (HRT) Therapeutic Market, US, (Year), 2017
- Hormone Replacement Therapy (HRT) Marketed Drugs, API Manufacturers by US DMF Status (%), 2017
- Hormone Replacement Therapy (HRT) Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Hormone Replacement Therapy (HRT) Drugs, API Manufacturers, Europe by Country, 2017
- Hormone Replacement Therapy (HRT) Drugs, API Manufacturers, India by State, 2017
- Hormone Replacement Therapy (HRT) Drugs, API Manufacturers, China by Province, 2017
- Hormone Replacement Therapy (HRT) Drugs, API Manufacturers by Geography 2017
- Hormone Replacement Therapy (HRT) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Hormone Replacement Therapy (HRT) Therapeutic Market, Global Sales 2018 (in million USD)
- Drug, Patent/Exclusivity Expiry (Year), 2017

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Hormone Replacement Therapy (HRT) Market Research Report 2016

Global Hormone Replacement Therapy (HRT) Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Hormone Replacement Therapy (HRT) Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hormone Replacement Therapy (HRT) industry, ...

EU: Hormones, Prostaglandins, Thromboxanes And LEUkotrienes - Market Report. Analysis And Forecast To 2020

EU: Hormones, Prostaglandins, Thromboxanes And LEUkotrienes - Market Report. Analysis And Forecast To 2020

  • $ 2161
  • Industry report
  • December 2016
  • by IndexBox Marketing

The report provides an in-depth analysis of the EU market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes. It presents the latest data of the market size and volume, domestic production, exports ...

EU: Hormones, Prostaglandins, Thromboxane And Leukotriene - Market Report. Analysis And Forecast To 2020

EU: Hormones, Prostaglandins, Thromboxane And Leukotriene - Market Report. Analysis And Forecast To 2020

  • $ 2161
  • Industry report
  • December 2016
  • by IndexBox Marketing

The report provides an in-depth analysis of the EU hormone market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the ...


Download Unlimited Documents from Trusted Public Sources

OTC Industry in Spain

  • February 2017
    4 pages
  • Vitamin  

  • Spain  

View report >

Global Milk Markets

  • January 2017
    2 pages
  • Milk  

  • World  

View report >

Salicylic Acid Market and Breast Cancer Statistics in the UK and the US

  • January 2017
    6 pages
  • Salicylic Acid  

    Breast Cancer  

    Pain Relief  

  • United Kingdom  

    United States  

View report >

Otc Industry In The Us

2 months ago

Related Market Segments :

Hormones

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.